Axa S.A. Viatris Inc Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Viatris Inc stock. As of the latest transaction made, Axa S.A. holds 1,500,587 shares of VTRS stock, worth $19.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,500,587

Previous 1,783,926 15.88%

Holding current value

$19.5 Million

Previous $19 Million 8.13%

% of portfolio

0.05%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.32 - $12.13 $2.92 Million - $3.44 Million	-283,339 Reduced 15.88%	1,500,587 $17.4 Million
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $3.3 Million - $3.95 Million	-328,824 Reduced 15.56%	1,783,926 $19 Million
Q1 2024 May 15, 2024	BUY	$11.27 - $13.53 $1.63 Million - $1.95 Million	144,213 Added 7.33%	2,112,750 $25.2 Million
Q4 2023 Jul 16, 2024	SELL	$8.77 - $10.85 $1.26 Million - $1.56 Million	-144,213 Reduced 6.83%	1,968,537 $21.3 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $807,164 - $998,601	-92,037 Reduced 4.47%	1,968,537 $21.3 Million
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $3.42 Million - $4.05 Million	356,857 Added 20.95%	2,060,574 $20.3 Million
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $453,606 - $517,473	50,289 Added 3.04%	1,703,717 $17 Million
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $2 Million - $2.66 Million	-216,890 Reduced 11.6%	1,653,428 $15.9 Million
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $1.42 Million - $1.88 Million	163,019 Added 9.55%	1,870,318 $20.8 Million
Q3 2022 Feb 14, 2023	BUY	$8.48 - $11.13 $3.08 Million - $4.04 Million	363,308 Added 27.03%	1,707,299 $14.5 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $3.08 Million - $4.04 Million	363,308 Added 27.03%	1,707,299 $14.5 Million
Q2 2022 Feb 14, 2023	BUY	$9.95 - $12.27 $12.6 Million - $15.5 Million	1,262,291 Added 1545.03%	1,343,991 $14.1 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $12.6 Million - $15.5 Million	1,262,291 Added 1545.03%	1,343,991 $14.1 Million
Q1 2022 Feb 14, 2023	SELL	$9.81 - $15.4 $15.9 Million - $25 Million	-1,625,599 Reduced 95.21%	81,700 $888,000
Q1 2022 May 13, 2022	SELL	$9.81 - $15.4 $18.3 Million - $28.8 Million	-1,867,150 Reduced 95.81%	81,700 $889,000
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $6.43 Million - $7.81 Million	-532,062 Reduced 21.45%	1,948,850 $26.4 Million
Q3 2021 Nov 15, 2021	BUY	$13.25 - $15.13 $24.6 Million - $28.1 Million	1,858,248 Added 298.44%	2,480,912 $33.6 Million
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $8.83 Million - $11 Million	-680,820 Reduced 52.23%	622,664 $8.9 Million
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $3.28 Million - $4.48 Million	-241,406 Reduced 15.63%	1,303,484 $18.2 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $22.1 Million - $29 Million	1,544,890 New	1,544,890 $29 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account